Ceo
CurrentDeveloped a UV treated, low temperature dried milk protein concentrate that retains 93% of raw milk's immune active proteins. Initial applications focus on sports nutrition, immune system support and regeneration, reducing allergy development in children and elderly nutrition. A UC Davis clinical trial demonstrated TruActive increased vaccine response by 120% in an elderly population. Recently received EU approval. Organizing a clinical trial on childhood allergy prevention. Patent filed and obtaining FDA approval in 2022. Currently working to initiated production of TruActive MPC 85 and TruActive WPI 90 in Europe and expand global regulatory approvals.